Liberman L, Abramson A F, Squires F B, Glassman J R, Morris E A, Dershaw D D
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
AJR Am J Roentgenol. 1998 Jul;171(1):35-40. doi: 10.2214/ajr.171.1.9648759.
The purpose of the study was to assess the positive predictive value of mammographic features and final assessment categories described in the Breast Imaging Reporting and Data System (BI-RADS) for lesions on which biopsies have been performed.
We prospectively evaluated 492 impalpable mammographically detected lesions on which surgical biopsy (as opposed to percutaneous biopsy) was performed. Each lesion was classified according to BI-RADS descriptors for masses (margins and shape) and calcifications (morphology and distribution) and was categorized by the BI-RADS final assessment categories as category 3 ("probably benign"), category 4 ("suspicious abnormality"), or category 5 ("highly suggestive of malignancy"). Mammographic and pathologic findings were reviewed.
Carcinoma was present in 225 (46%) of 492 lesions. For the 492 lesions subject to biopsy, BI-RADS final assessment categories were category 3 in eight lesions (2%), category 4 in 355 (72%), and category 5 in 129 (26%). The features with highest positive predictive value for carcinoma were spiculated margins (81%), irregular shape (73%), linear calcification morphology (81%), and segmental or linear calcification distribution (74% and 68%, respectively). Carcinoma was present in 105 (81%) of 129 category 5 lesions compared with 120 (34%) of 355 category 4 lesions (p < .001). The frequency of carcinoma was higher in category 5 than in category 4 lesions for all mammographic lesion types and all interpreting radiologists.
The standardized terminology of the BI-RADS lexicon allows quantification of the likelihood of carcinoma in an impalpable breast lesion. The features with highest positive predictive value--spiculated margins, irregular shape, linear morphology, and segmental or linear distribution--warrant designation of a lesion as category 5.
本研究旨在评估乳腺影像报告和数据系统(BI-RADS)中描述的乳腺钼靶特征及最终评估类别对已进行活检的病变的阳性预测价值。
我们前瞻性评估了492个乳腺钼靶检查发现但触诊不到的病变,这些病变均接受了外科活检(而非经皮活检)。每个病变根据BI-RADS对肿块(边缘和形状)及钙化(形态和分布)的描述符进行分类,并按照BI-RADS最终评估类别分为3类(“可能为良性”)、4类(“可疑异常”)或5类(“高度怀疑为恶性”)。对乳腺钼靶和病理结果进行了回顾。
492个病变中有225个(46%)为癌。在接受活检的492个病变中,BI-RADS最终评估类别为3类的有8个(2%),4类的有355个(72%),5类的有129个(26%)。对癌具有最高阳性预测价值的特征为毛刺状边缘(81%)、不规则形状(73%)、线性钙化形态(81%)以及节段性或线性钙化分布(分别为74%和68%)。129个5类病变中有105个(81%)为癌,而355个4类病变中有120个(34%)为癌(p < 0.001)。对于所有乳腺钼靶病变类型及所有解读放射科医生,5类病变中癌的发生率均高于4类病变。
BI-RADS词汇表的标准化术语能够对触诊不到的乳腺病变中癌的可能性进行量化。具有最高阳性预测价值的特征——毛刺状边缘、不规则形状、线性形态以及节段性或线性分布——足以将病变定为5类。